Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01719562 · ClinicalTrials.gov registry record · NA
MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT01719562 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 28 participants.
The verdict
NCT01719562, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
This trial studies how well magnetic resonance imaging (MRI) works in detecting heart damage in patients with cancer receiving chemotherapy. Diagnostic procedures, such as MRI, may help doctors predict whether patients will have heart damage caused by chemotherapy in patients with cancer receiving chemotherapy. Exercise Capacity Addendum Brief Summary: This study is designed to demonstrate feasibility of performing the physical activity intervention and the primary outcome measures before, during and six months after initiating Anth-bC for treatment of non- or Hodgkin lymphoma. This study will test the potential for a novel (lifestyle) intervention designed to improve exercise capacity, health-related quality of life and cardiac and cognitive dysfunction. This data will inform the development of the R33 phase of the clinical trial to determine if the physical activity intervention can reduce exercise intolerance in this high-risk population. In addition, cardiac MRI data from individuals within this pilot will be compared to cardiac MRI data from individuals in the parent study that did not undergo either of the two interventional arms of this study.
Interventions
- OTHER Questionnaire Administration
- PROCEDURE Magnetic resonance imaging
- OTHER Physical Activity
- OTHER Healthy Living
- DEVICE Cardiopulmonary Exercise Testing (CPET)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2013-01-01 |
| Est. Completion | 2022-03-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01719562
The ClinicalTrials.gov registry entry for NCT01719562 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Questionnaire Administration is the first listed.
NCT01719562 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01719562 about?
NCT01719562 is a clinical study titled "MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum". This trial studies how well magnetic resonance imaging (MRI) works in detecting heart damage in patients with cancer receiving chemotherapy. Diagnostic procedures, such as MRI, may help doctors predict whether patients will have heart damage caused by chemotherapy in patients with cancer receiving c...
What is the current status of trial NCT01719562?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2013-01-01. Estimated completion is 2022-03-08.
What interventions are being tested in trial NCT01719562?
The interventions under investigation include: Questionnaire Administration (OTHER), Magnetic resonance imaging (PROCEDURE), Physical Activity (OTHER), Healthy Living (OTHER), Cardiopulmonary Exercise Testing (CPET) (DEVICE).
Who is sponsoring clinical trial NCT01719562?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.